Form D · Biotechnology
OMNISEQ, INC.
Buffalo, NY · CIK 0001713983
Offering snapshot reported Jun 21, 2019 · SEC filing
- Reported sold
- $1.57M Offering amount: $1.57M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 21, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 21, 2019 | Initial | $1,568,650 | No comparison | 4 | SEC filing |
| May 3, 2019 | Initial | $7,325,000 | No comparison | 1 | SEC filing |
| Aug 18, 2017 | Initial | $10,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-342466
Source: Form D, filed Jun 21, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven Anderson | Director |
| Paul Billings | Director |
| Marcia Eisenberg | Director |
| Mark Gardner | Director |
| Mark Garner | Director, Executive |
| Candace Johnson | Director |
| Kenneth Manning | Director |
| Carl Morrison | Director |
| Margot Schoenborn | Director, Executive |
| R. Buford Sears | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
700 Ellicott Street
Buffalo, NY, 14203
Buffalo, NY, 14203